Skip to content

King Pharmaceuticals KG Other (predominantly Europe) — Net premiums earned

Other geography segments

North America
-$80K

Similar metrics at other companies

Mercury General logo
MCYOther — Net premiums earned
$91.7M+25.3%
Bowhead Specialty Holdings logo
BOWNet premiums earned
$136.81M+24.6%
American Coastal Insurance Corporation logo
ACICNet premiums earned
$76.71M+12.0%
Selective Insurance Group logo
SIGIOther — Net premiums earned
$3.29M+19.7%
Mercury General logo
MCYOther — Premiums Earned, Net
$7.3M0.0%
Cavco Industries logo
CVCONet premiums earned
$14.79M-5.7%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's other (predominantly europe) — net premiums earned.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's other (predominantly europe) — net premiums earned?
King Pharmaceuticals (KG) reported other (predominantly europe) — net premiums earned of $3.19M in Q4 2025.
What does other (predominantly europe) — net premiums earned mean?
This metric represents the portion of net premiums written that is recognized as revenue over the period as the insurance coverage is provided. It is the core revenue figure used to calculate underwriting profitability and efficiency ratios for the segment. By focusing on earned premiums rather than written premiums, investors can better align revenue recognition with the actual risk exposure period.